首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Antisense Growth Inhibition of Methicillin-Resistant Staphylococcus aureus by Locked Nucleic Acid Conjugated with Cell-Penetrating Peptide as a Novel FtsZ Inhibitor
【2h】

Antisense Growth Inhibition of Methicillin-Resistant Staphylococcus aureus by Locked Nucleic Acid Conjugated with Cell-Penetrating Peptide as a Novel FtsZ Inhibitor

机译:锁定核酸与细胞穿透肽结合的新型FtsZ抑制剂对耐甲氧西林金黄色葡萄球菌的反义生长抑制

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Methicillin-resistant Staphylococcus aureus (MRSA) infections are becoming increasingly difficult to treat, owing to acquired antibiotic resistance. The emergence and spread of MRSA limit therapeutic options and require new therapeutic strategies, including novel MRSA-active antibiotics. Filamentous temperature-sensitive protein Z (FtsZ) is a highly conserved bacterial tubulin homologue that is essential for controlling the bacterial cell division process in different species of S. aureus. We conjugated a locked nucleic acid (LNA) that targeted ftsZ mRNA with the peptide (KFF)3K, to generate peptide-LNA (PLNA). The present study aimed to investigate whether PLNA could be used as a novel antibacterial agent. PLNA787, the most active agent synthesized, exhibited promising inhibitory effects on four pathogenic S. aureus strains in vitro. PLNA787 inhibited bacterial growth and resolved lethal Mu50 infections in epithelial cell cultures. PLNA787 also improved the survival rates of Mu50-infected mice and was associated with reductions of bacterial titers in several tissue types. The inhibitory effects on ftsZ mRNA and FtsZ protein expression and inhibition of the bacterial cell division process are considered to be the major mechanisms of PLNA. PLNA787 demonstrated activity against MRSA infections in vitro and in vivo. Our findings suggest that ftsZ mRNA is a promising new target for developing novel antisense antibiotics.
机译:由于获得性抗生素耐药性,耐甲氧西林金黄色葡萄球菌(MRSA)感染正变得越来越难以治疗。 MRSA的出现和传播限制了治疗选择,并需要新的治疗策略,包括新型MRSA活性抗生素。丝状温度敏感蛋白Z(FtsZ)是高度保守的细菌微管蛋白同源物,对于控制金黄色葡萄球菌不同物种中的细菌细胞分裂过程至关重要。我们将锁定ftsZ mRNA的锁定核酸(LNA)与肽(KFF)3K结合,以生成肽LNA(PLNA)。本研究旨在调查PLNA是否可以用作新型抗菌剂。合成的活性最高的PLNA787在体外对四种致病性金黄色葡萄球菌菌株表现出有希望的抑制作用。 PLNA787抑制细菌生长并解决了上皮细胞培养物中的致命性Mu50感染。 PLNA787还提高了Mu50感染小鼠的存活率,并且与几种组织类型中细菌滴度的降低有关。对ftsZ mRNA和FtsZ蛋白表达的抑制作用以及对细菌细胞分裂过程的抑制被认为是PLNA的主要机制。 PLNA787在体外和体内均表现出抗MRSA感染的活性。我们的发现表明,ftsZ mRNA是开发新型反义抗生素的有希望的新靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号